Showing results (131-140 of 161) with videos related to
Sort By:
Pageof 17
Journal of Endocrinological Investigation|July 15, 2006
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid)M V Davì, L Bodei, G Francia, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanomaP Magnani, G Paganelli, G Modorati, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2020
Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patientsM Celli, U De Giorgi, P Caroli, et al.Biopolymers|March 27, 2003
90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignanciesG Paganelli, L Bodei, D Handkiewicz Junak, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2015
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumorsL Bodei, M Kidd, I M Modlin, et al.The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco, M Pizzamiglio, G Trifirò, et al.Nuclear Medicine Communications|October 21, 1999
Radiation protection in radioguided surgery of breast cancerM Cremonesi, M Ferrari, E Sacco, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 9, 2012
Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL)S Zovato, A Kumanova, S Demattè, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Safety of sentinel node biopsy in pregnant patients with breast cancerO Gentilini, M Cremonesi, G Trifirò, et al.Pageof 17